A WORD FROM OUR DI RECTOR
Professor Dale Bailey
Director , Sydney Vital Flagship Lead , Translational Theranostics
Sydney its seventh year of operation as a fully - fledged Translational Cancer Research Centre . Along the way priorities have shifted where necessary and research activities modified , however , our focus has remained on patient - centred translational cancer research . Vital is now entering “ Translational ” means that we try to take concepts that look promising and take them into practice in the clinic or to fill a void in patient care . Our ultimate measure of success is the outcome for cancer patients in New South Wales . It is therefore pleasing , though not yet satisfactory , to see in the latest national cancer statistics that patients with cancer in the Northern Sydney Local Health District have some of the best outcomes in Australia . There is no one single reason for this , yet , having an environment where patient management is discussed regularly by a multi - disciplinary team of clinicians and researchers with a strong research focus is part of the formula . At Sydney Vital we aim to turbo - charge existing activities in our region in cancer research , train the next generation of clinicians / researchers , create opportunities to better inform our community about the latest advances in cancer care , and serve as a stepping stone to launch junior clinicians and researchers into the next phase of their careers .
Over our seven years we have been able to support in excess of 130 clinicians and researchers , many of whom have gone on to develop their own careers based on their research experience supported by Sydney Vital . One of last year ’ s research fellows , Dr David Chan , was successful at his first attempt in securing a five year NHMRC Investigator Award which will allow him to continue the research that he started with Sydney Vital . The first half of 2020 is a time like no other for the majority of us . I am pleased to be able to report that the research activities of Sydney Vital have been able to continue due to the passion and commitment that our researchers and professional staff possess . “ Social distancing ” has not meant that successes have become more distant . Our current programme grant has less than a year to run and we are yet to find out whether our program will be renewed by CINSW and the University of Sydney from July 2021 . We are all anticipating a different future and a “ new normal ” when we finally reach the other side of the COVID - 19 pandemic . Hopefully , this will be a brave new world , but no matter what form that takes we know that Sydney vital has made a tangible contribution to the current and future generation of cancer clinicians and researchers .
P A G E 0 2
Made with FlippingBook - professional solution for displaying marketing and sales documents online